A carregar...
The development of activatable lytic peptides for targeting triple negative breast cancer
Cytolytic peptides are an emerging class of promising cancer therapeutics shown to overcome drug resistance. They eliminate cancer cells via disruption of the phospholipid bilayer of cell membranes, a mechanism that differentiates it from traditional treatments. However, applications of lytic peptid...
Na minha lista:
| Publicado no: | Cell Death Discov |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629628/ https://ncbi.nlm.nih.gov/pubmed/29263848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2017.37 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|